Financings in Brief: Aurora Biosciences
This article was originally published in The Gray Sheet
Executive Summary
Aurora Biosciences: Drug discovery system firm goes public in an offering of 4 mil. shares for $10 each. Aurora, based in La Jolla, California, says it will use proceeds to fund "working capital and general corporate purposes, including enhancement of research and development capabilities, the acquisition of chemical libraries, and facilities expansion and improvements." Alex. Brown served as lead underwriter for the offering; Hambrecht & Quist and Robertson, Stephens were co-managers. Underwriters hold an over-allotment option to buy 600,000 additional shares...